BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34189537)

  • 1. SARS-CoV-2 under an elimination strategy in Hong Kong.
    Gu H; Xie R; Adam DC; Tsui JL; Chu DK; Chang LDJ; Cheuk SSY; Gurung S; Krishnan P; Ng DYM; Liu GYZ; Wan CKC; Edwards KM; Leung KSM; Wu JT; Tsang DNC; Leung GM; Cowling BJ; Peiris M; Lam TTY; Dhanasekaran V; Poon LLM
    medRxiv; 2021 Jun; ():. PubMed ID: 34189537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic epidemiology of SARS-CoV-2 under an elimination strategy in Hong Kong.
    Gu H; Xie R; Adam DC; Tsui JL; Chu DK; Chang LDJ; Cheuk SSY; Gurung S; Krishnan P; Ng DYM; Liu GYZ; Wan CKC; Cheng SSM; Edwards KM; Leung KSM; Wu JT; Tsang DNC; Leung GM; Cowling BJ; Peiris M; Lam TTY; Dhanasekaran V; Poon LLM
    Nat Commun; 2022 Feb; 13(1):736. PubMed ID: 35136039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of COVID-19 cases and the successful containment strategy in Hong Kong-January to May 2020.
    Lam HY; Lam TS; Wong CH; Lam WH; Leung CME; Au KWA; Lam CKY; Lau TWW; Chan YWD; Wong KH; Chuang SK
    Int J Infect Dis; 2020 Sep; 98():51-58. PubMed ID: 32579906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Air travel-related outbreak of multiple SARS-CoV-2 variants.
    Dhanasekaran V; Edwards KM; Xie R; Gu H; Adam DC; Chang LDJ; Cheuk SSY; Gurung S; Krishnan P; Ng DYM; Liu GYZ; Wan CKC; Cheng SSM; Tsang DNC; Cowling BJ; Peiris M; Poon LLM
    J Travel Med; 2021 Dec; 28(8):. PubMed ID: 34542623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of control and transmission of COVID-19 across epidemic waves in Hong Kong: an observational study.
    Yang B; Lin Y; Xiong W; Liu C; Gao H; Ho F; Zhou J; Zhang R; Wong JY; Cheung JK; Lau EHY; Tsang TK; Xiao J; Wong IOL; Martín-Sánchez M; Leung GM; Cowling BJ; Wu P
    Lancet Reg Health West Pac; 2024 Feb; 43():100969. PubMed ID: 38076326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving Epidemiological Characteristics of COVID-19 in Hong Kong From January to August 2020: Retrospective Study.
    Kwok KO; Wei WI; Huang Y; Kam KM; Chan EYY; Riley S; Chan HHH; Hui DSC; Wong SYS; Yeoh EK
    J Med Internet Res; 2021 Apr; 23(4):e26645. PubMed ID: 33750740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Evolution of Human Coronavirus 229E in Hong Kong and a Fatal COVID-19 Case Involving Coinfection with a Novel Human Coronavirus 229E Genogroup.
    Lau SKP; Lung DC; Wong EYM; Aw-Yong KL; Wong ACP; Luk HKH; Li KSM; Fung J; Chan TTY; Tang JYM; Zhu L; Yip CCY; Wong SCY; Lee RA; Tsang OTY; Yuen KY; Woo PCY
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33568452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phylogenomic analysis of COVID-19 summer and winter outbreaks in Hong Kong: An observational study.
    Chan WM; Ip JD; Chu AW; Tse H; Tam AR; Li X; Kwan MY; Yau YS; Leung WS; Chik TS; To WK; Ng AC; Yip CC; Poon RW; Chan KH; Wong SC; Choi GK; Lung DC; Cheng VC; Hung IF; Yuen KY; To KK
    Lancet Reg Health West Pac; 2021 May; 10():100130. PubMed ID: 33778795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of within-hotel transmission of SARS-CoV-2 during on-arrival quarantine in Hong Kong: an epidemiological and phylogenomic investigation.
    Adam DC; Martín-Sánchez M; Gu H; Yang B; Lin Y; Wu P; Lau EHY; Leung GM; Poon LLM; Cowling BJ
    Lancet Reg Health West Pac; 2023 Apr; 33():100678. PubMed ID: 36643735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of community acquired of SARS-CoV-2 lineage B.1.351 in Hong Kong.
    Tsang AKL; Mak GCK; Cheng PKC; Yip PCW; Ng KHL; Lam ETK; Chan RCW; Tsang DNC
    J Clin Virol Plus; 2021 Sep; 1(3):100029. PubMed ID: 35262015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Diversity of SARS-CoV-2 among Travelers Arriving in Hong Kong.
    Gu H; Chu DKW; Chang LDJ; Cheuk SSY; Gurung S; Krishnan P; Ng DYM; Liu GYZ; Wan CKC; Xie R; Cheng SSM; Cowling BJ; Tsang DNC; Peiris M; Dhanasekaran V; Poon LLM
    Emerg Infect Dis; 2021 Oct; 27(10):2666-2668. PubMed ID: 34545799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution and Control of COVID-19 Epidemic in Hong Kong.
    Wong SC; Au AK; Lo JY; Ho PL; Hung IF; To KK; Yuen KY; Cheng VC
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring International Travelers Arriving in Hong Kong for Genomic Surveillance of SARS-CoV-2.
    Gu H; Cheng SSM; Krishnan P; Ng DYM; Chang LDJ; Liu GYZ; Cheuk SSY; Hui MMY; Fan MCY; Wan JHL; Lau LHK; Chu DKW; Dhanasekaran V; Peiris M; Poon LLM
    Emerg Infect Dis; 2022 Jan; 28(1):247-250. PubMed ID: 34932453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome.
    Guan Y; Peiris JS; Zheng B; Poon LL; Chan KH; Zeng FY; Chan CW; Chan MN; Chen JD; Chow KY; Hon CC; Hui KH; Li J; Li VY; Wang Y; Leung SW; Yuen KY; Leung FC
    Lancet; 2004 Jan; 363(9403):99-104. PubMed ID: 14726162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of BNT162b2 and Sinovac vaccines against the transmission of SARS-CoV-2 during Omicron-predominance in Hong Kong: A retrospective cohort study of COVID-19 cases.
    Zhao S; Guo Z; Sun S; Hung CT; Leung EYM; Wei Y; Wang H; Li K; Yam CHK; Chow TY; Gao J; Jia KM; Chong KC; Yeoh EK
    J Clin Virol; 2023 Sep; 166():105547. PubMed ID: 37453162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong.
    Cheng VCC; Wong SC; Chen JHK; Yip CCY; Chuang VWM; Tsang OTY; Sridhar S; Chan JFW; Ho PL; Yuen KY
    Infect Control Hosp Epidemiol; 2020 May; 41(5):493-498. PubMed ID: 32131908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying the improvement in confirmation efficiency of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the early phase of the outbreak in Hong Kong in 2020.
    Ran J; Zhao S; Zhuang Z; Chong MKC; Cai Y; Cao P; Wang K; Lou Y; Wang W; Gao D; Yang L; He D; Wang MH
    Int J Infect Dis; 2020 Jul; 96():284-287. PubMed ID: 32413609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
    Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
    Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A small number of early introductions seeded widespread transmission of SARS-CoV-2 in Québec, Canada.
    Murall CL; Fournier E; Galvez JH; N'Guessan A; Reiling SJ; Quirion PO; Naderi S; Roy AM; Chen SH; Stretenowich P; Bourgey M; Bujold D; Gregoire R; Lepage P; St-Cyr J; Willet P; Dion R; Charest H; Lathrop M; Roger M; Bourque G; Ragoussis J; Shapiro BJ; Moreira S
    Genome Med; 2021 Oct; 13(1):169. PubMed ID: 34706766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.